by Simon Johnson | Feb 28, 2022 | Research
Abstract Vaccination against viruses has rarely been associated with Guillain-Barré syndrome (GBS). An association with the COVID-19 vaccine is unknown. We performed a population-based study of National Health Service data in England and a multicentre surveillance...
by Simon Johnson | Jan 13, 2022 | Research
Falls in people post-Guillain-Barré syndrome in the United Kingdom: A national cross-sectional survey of community based adults Guillain-Barré syndrome (GBS) has several enduring effects that can lead to further harm and/or lower quality of life. These effects include...
by Simon Johnson | Sep 1, 2021 | Health
Acute inflammatory demyelinating polyneuropathy (AIDP), characterised by the autoimmune destruction of Schwann cells with resultant myelin degradation, is the most common subtype of Guillain-Barré Syndrome (GBS). GBS encompasses a myriad of autoimmune...
by Simon Johnson | Feb 4, 2021 | Research
The study was funded by the GAIN charity and led by Prof Niro Siriwardena, with a team including Despina Laparidou and Dr Joseph Akanuwe from CaHRU, Dr Ffion Curtis from Lincoln International Institute for Rural Health, Dr Jennifer Jackson (Lincoln International...
by Sarah | Jan 23, 2020 | Your Stories
Developing Guillain-Barre syndrome means everything grinds to a halt for a while. Andy Ingham tells us about returning to work as he started to get his life back. It’s a funny old world. One day I’m living my life as usual, juggling home and work life, having...
